Advanced search

Report side effect

Report a suspected side effect or falsified product to the MHRA Yellow Card scheme.
Go to {yellow_card_logo} site
{arrow_up} Back to top

Emerade 300 micrograms, solution for injection in pre-filled pen

Discontinued
Active Ingredient:
adrenaline tartrate
Company:  
Bausch & Lomb U.K Limited See contact details
ATC code: 
C01CA24
{info_black}
About Medicine
{medical_services}
Prescription only medicine
Patient Leaflet (PIL) Risk Materials Letters to HCPs Safety Alert HCP Med Info
{arrow_left}
{arrow_right}

Important information for Healthcare Professionals

{pdf_link}

Emerade 300mcg and 500mcg class 1 recall

{healthcare_pro_orange} For Healthcare Professionals
All batches of unexpired Emerade 300mcg and Emerade 500mcg adrenaline autoinjectors (pens) are being recalled from patients. This is due to an issue identified during ISO 11608 Design Assessment study where some auto-injectors failed to deliver product or activated prematurely.

You are trying to reach document intended for healthcare professionals only.

Are you a healthcare professional?

Log in or sign up to avoid further verifications.

Bausch & Lomb U.K Limited
Company image
Address
Bausch & Lomb House, 106 London Road, Kingston-upon-Thames, Surrey, KT2 6TN, UK
Telephone
+44 (0)208 781 2900
Medical Information e-mail
[email protected]
Customer Care direct line
Tel: +44 (0)208 781 2991 Fax: +44 (0)208 781 295